- Filed
- May 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 21, 2025 | 1.88B sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $552.48K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $472.87K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $648.89K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $472.87K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $229.84K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $219.33K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $340.21K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $219.33K |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.88B sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$59.42K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$169.76K |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$74.06K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$95.7K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $60.49K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $215.25K |
| Revenue | Q1 2025 · Mar 31, 2024 | $275.74K |